Filing Details

Accession Number:
0000711377-19-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 16:15:08
Reporting Period:
2019-05-06
Accepted Time:
2019-05-08 16:15:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-06 7,600 $29.71 45,175 No 4 M Direct
Common Stock Disposition 2019-05-06 7,600 $61.69 37,575 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2019-05-06 7,600 $0.00 7,600 $29.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
143,802 2019-10-31 No 4 M Direct
Footnotes
  1. Options were granted 10-1-2014, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant